News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Global markets showed limited movement with major indices trading near unchanged levels this hour.
  • US Treasury yields were little changed, leaving fixed-income markets quiet.
  • Dollar trading lacked clear direction against major currencies, keeping FX markets subdued.
  • No significant economic data or central bank announcements were released in the past hour.
  • Market volatility indicators remained low, suggesting risk sentiment stayed stable over the hour.

Latest Articles

UBS Lowers Avolta to Neutral, Cuts Price Target by Nearly a Quarter Citing Middle East-Driven Airline Risk

UBS Lowers Avolta to Neutral, Cuts Price Target by Nearly a Quarter Citing Middle East-Driven Airline Risk

UBS downgraded Avolta from Buy to Neutral and reduced its 12-month price target to CHF48 from CHF63, pointing to heightened earnings risk stemming from the Middle East conflict and resulting disruptions in the airline industry. The bank lowered near-term EPS and organic sales growth forecasts, adjusted margin and discount-rate assumptions, and outl…

Tight Race in Brazil as Lula and Flavio Bolsonaro Neck-and-Neck in Runoff Simulation

Tight Race in Brazil as Lula and Flavio Bolsonaro Neck-and-Neck in Runoff Simulation

A recent AtlasIntel/Bloomberg poll indicates that President Luiz Inacio Lula da Silva and Senator Flavio Bolsonaro are virtually level in a simulated second-round matchup, with the two candidates separated by a narrow margin well within the survey's reported error. First-round simulations also show Lula leading but without a clear majority, leaving…

InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

InflaRx N.V., a biopharmaceutical company focused on anti-inflammatory therapies, has announced that it has regained compliance with Nasdaq's minimum bid price requirement after its ordinary shares closed at or above $1.00 for 10 consecutive business days. This compliance removes the risk of delisting and bolsters confidence in the company's stock.

Watsco To Acquire Jackson Supply Company

Watsco To Acquire Jackson Supply Company

Watsco, Inc., the largest North American HVAC/R distributor, announced a definitive agreement to acquire Jackson Supply Company, a leading HVAC distributor in the Sunbelt region with $230 million in revenue and 25 locations. The acquisition is expected to close in Q2 2026, enhancing Watsco's scale in high-growth markets and leveraging technology pl…

ZenaTech's ZenaDrone Subsidiary and Defense Solutions in the Spotlight at Company’s Largest Ever Presence at AUVSI Exponential 2026 Conference and Tradeshow in Detroit

ZenaTech's ZenaDrone Subsidiary and Defense Solutions in the Spotlight at Company’s Largest Ever Presence at AUVSI Exponential 2026 Conference and Tradeshow in Detroit

ZenaTech, Inc. (Nasdaq: ZENA) announced that its subsidiary ZenaDrone will showcase its most comprehensive defense-focused drone hardware, software, and Drone as a Service (DaaS) at the AUVSI Xponential 2026 conference in Detroit. The company will engage defense, government, and enterprise stakeholders with live demonstrations, a podcast studio, an…

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

Harvard Bioscience, a life sciences technology developer, declared that it will release quarterly financial results for Q1 2026 on May 12 before market open and host a conference call to discuss these results. The company provides technologies and services supporting research and pharmaceutical development globally, with operations in the US, Europ…

NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans

NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans

NorthStrive Biosciences Inc., a subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), announced the filing of a new US patent application covering the development of EL-22, a myostatin-engineered probiotic technology, for pharmaceutical use targeting muscle loss conditions in humans. The patent includes protection for specific dosing regimens and formul…

Streamex Corp. Announces First Yield Dividend Distribution for GLDY

Streamex Corp. Announces First Yield Dividend Distribution for GLDY

Streamex Corp. (NASDAQ: STEX) announced the first yield distribution for GLDY, a gold-backed, yield-bearing tokenized security. The yield, generated through a gold leasing program with an annualized lease yield of 3.5%, is distributed in additional GLDY tokens monthly. This milestone validates Streamex's infrastructure and product, bridging traditi…

Watsco First Quarter Performance Reflects Stabilizing Markets,  Improved Operating Efficiency and Expanded Technology Adoption

Watsco First Quarter Performance Reflects Stabilizing Markets, Improved Operating Efficiency and Expanded Technology Adoption

Watsco, Inc., the leading North American HVAC distributor, reported flat first quarter 2026 revenues and earnings, reflecting market stabilization following the A2L refrigerant transition. The company announced the pending acquisition of Jackson Supply Company, enhancing scale and diversification in its core Sunbelt markets. Watsco continues to inv…

Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Helus Pharma has partnered with mental health organization TARA Mind to support recruitment for its Phase 3 clinical trial of HLP003, a novel serotonergic agonist for major depressive disorder, specifically targeting veterans. This collaboration aligns with a recent U.S. Executive Order focusing on accelerating treatments for serious mental illness…

BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White

BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White

BridgeBio Pharma initiates a national educational campaign highlighting ATTR-CM, a frequently overlooked heart condition, to encourage earlier diagnosis and treatment. The campaign features advocates Morgan Freeman and Howard H. White and promotes their drug, Attruby®, which showed significant clinical benefits in reducing cardiovascular-related ho…

Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress

Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress

Cytokinetics announced nine presentations at the European Society of Cardiology Heart Failure 2026 Congress, focusing largely on its cardiac myosin inhibitor MYQORZO® (aficamten), recently approved in major markets including the US, Europe, and China for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). The presentations will highlight cl…

3D Systems Secures Class IIa EU MDR Certification for NextDent® Jetted Denture Solution, Enabling Full European Commercial Launch Two Months Ahead of Schedule

3D Systems Secures Class IIa EU MDR Certification for NextDent® Jetted Denture Solution, Enabling Full European Commercial Launch Two Months Ahead of Schedule

3D Systems announced that its NextDent Jet Base and Jet Teeth materials, along with the NextDent 300 MultiJet 3D printer, have achieved Class IIa certification under the EU Medical Device Regulation. This certification allows the immediate commercial launch of its flagship jetted denture solution across Europe two months ahead of schedule, signific…

Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics announced a new coverage agreement with Blue Shield of California for its CNSide® cerebrospinal fluid tumor cell assay, a diagnostic tool for metastatic CNS cancers. This agreement increases total covered lives from 75 million to 81 million, supporting the company's goal of 150 million by 2026 and enhancing adoption by reducing re…

U.S. Futures Mixed as Corporate Earnings and Geopolitical Moves Set the Tone

U.S. Futures Mixed as Corporate Earnings and Geopolitical Moves Set the Tone

U.S. stock futures were split in early trading as investors weighed a presidential decision on Iran's recent peace proposal alongside a busy slate of corporate earnings. Auto and beverage stocks gained on company-specific developments, while AI-linked cloud names and several miners retreated amid lower bullion prices and reports of missed targets a…